Mannatech (MTEX) risk factors, FY2024 10-K

Mannatech's FY2024 10-K, filed Mar 26, 2025, lists 40 risk factors in 3 groups. There is no earlier 10-K to compare against, so the most company-specific risks are listed below.

Risk factors listed
403 groups
Section length
12k wordsItem 1A

Mannatech's biggest risks in the FY2024 10-K

  • The company relies heavily on 133,000 independent associates, with 76.3% of net sales generated internationally.

The risks most specific to Mannatech

  • The loss of key high-level independent associate leaders could negatively impact our associate growth and our revenue

    As of December 31, 2024, 155 of our 133,000 active associates occupied the highest leadership levels under our global compensation plan.

  • An increase in the amount of commissions and incentives paid to independent associates could adversely affect our earnings

    Commissions and incentives paid to independent associates range from 35% to 43% of our consolidated net sales.

  • If we are unable to protect the proprietary rights of our products, our business could suffer

    We rely heavily on proprietary products like the Ambrotose complex and MTech AO Blend formulation.

  • Our business is not currently exposed to customer concentration risk given that no independent associate has ever accounted for more than 10% of our consolidated net sales

    The Republic of Korea serves as our largest market, creating geographic concentration risk.

  • We have outstanding debt with our directors. Such indebtedness could adversely affect our cash flow and our ability to pursue desirable business opportunities

    We entered into $3.6 million in unsecured loan and promissory note agreements with three directors and stockholders on April 23, 2024.

  • Risks Related to Our International Operations

    Currency exchange rate fluctuations could reduce our overall profits

    For the year ended December 31, 2024, we recognized 76.3% of net sales outside the United States.

  • Risks Related to Owning Our Common Stock

    Certain shareholders, directors, and officers own a significant amount of our stock, which could allow them to influence corporate transactions and other matters

    Directors and executive officers beneficially owned approximately 43.81% of our total outstanding common stock as of December 31, 2024.

  • Risks Related to Owning Our Common Stock

    Our failure to comply with The Nasdaq Capital Market continued listing standards may adversely affect the price and liquidity of our shares of common stock as well as our ability to raise capital in the future

    We transferred from The Nasdaq Global Select Market to The Nasdaq Capital Market after receiving a notice regarding our minimum net equity requirement.

All 40 risk factors

Headings as the filing states them, in filing order.

Other

  1. 01If we are unable to attract and retain independent associates, our business may suffer
  2. 02The loss of key high-level independent associate leaders could negatively impact our associate growth and our revenue
  3. 03Changes to our associate compensation arrangements could be viewed negatively by some independent associates, could cause failure to achieve desired long-term results and have a negative impact on revenue
  4. 04An increase in the amount of commissions and incentives paid to independent associates could adversely affect our earnings
  5. 05The loss of key management personnel could adversely affect our business, financial condition, results of operations or independent associate relations
  6. 06If we are unable to protect the proprietary rights of our products, our business could suffer
  7. 07Our inability to develop and introduce new products that gain independent associate, preferred customer, and market acceptance could harm our business
  8. 08Our failure to appropriately respond to changing consumer preferences and demand for new products or product enhancements could significantly harm our relationship with independent associates and preferred customers, our product sales, as well as our financial condition and operating results
  9. 09If our outside suppliers and manufacturers fail to supply products in sufficient quantities and in a timely fashion or fail to comply with our product safety and quality standards or applicable law, our business could suffer
  10. 10The loss of suppliers, shortages of raw materials or our failure to satisfy minimum purchase requirements could have an adverse effect on our business, financial condition, or results of operations
  11. 11If we are exposed to product liability claims, we may be liable for damages and expenses, which could affect our overall financial condition, results of operations and cash flows
  12. 12Our business is not currently exposed to customer concentration risk given that no independent associate has ever accounted for more than 10% of our consolidated net sales
  13. 13If we incur substantial liability from litigation, complaints, or enforcement actions or incur liabilities or penalties resulting from misconduct by our independent associates, our financial condition could suffer and could have a negative impact on our profitability and growth prospects
  14. 14The global nutrition and skin care industries are intensely competitive and the strengthening of any of our competitors could harm our business
  15. 15A downturn in the economy, could affect consumer purchases of discretionary items such as the health and wellness products that we offer, which could have an adverse effect on our business, financial condition, profitability, and cash flows
  16. 16Adverse or negative publicity could cause our business to suffer
  17. 17If our information technology system fails or if the implementation of new information technology systems is not executed efficiently and effectively, our business, financial position, and operating results could be adversely affected
  18. 18We use artificial intelligence in our business, and challenges with properly managing its use could result in reputational harm, competitive harm, and legal liability, and adversely affect our results of operations
  19. 19Interruption or failure of our information technology and communications systems could impair the delivery of our service and harm our business
  20. 20unplanned outages or technical difficulties. We could also experience loss of data or processing capabilities, which could cause us to lose customers and could harm our reputation and operating results
  21. 21We rely upon our existing cash balances and cash flow from operations to fund our business and meet our contractual obligations. In the event that we do not generate adequate cash flow from operations, we will need to raise money through a debt or equity financing, if available, or curtail operations
  22. 22We have outstanding debt with our directors. Such indebtedness could adversely affect our cash flow and our ability to pursue desirable business opportunities
  23. 23We are subject to liquidity risk, which could adversely affect our financial condition and results of operations

Risks Related to Our International Operations

  1. 24If our international markets are not successful, our business could suffer
  2. 25Currency exchange rate fluctuations could reduce our overall profits

Risks Related to Regulation

  1. 26If government regulations regarding network marketing change or are interpreted or enforced in a manner adverse to our business, we may be subject to new enforcement actions and material limitations regarding our overall business model
  2. 27Independent associates could fail to comply with our associate policies and procedures or make improper product, compensation, marketing or advertising claims that violate laws or regulations, which could result in claims against us that could harm our financial condition and operating results
  3. 28We may be held responsible for certain taxes or assessments relating to the activities of our independent associates, which could harm our financial condition and operating results
  4. 29Challenges by private parties to the form of our network marketing system could harm our business
  5. 30If our network marketing activities do not comply with government regulations, our business could suffer
  6. 31The Company may, directly or indirectly, be affected by government laws and regulations related to climate change
  7. 32If we violate governmental regulations or fail to obtain necessary regulatory approvals, our operations could be adversely affected
  8. 33selling companies. The suspension on issuing direct selling licenses remains in effect and it is unclear whether there will be changes to the application processes if and when the suspension is lifted
  9. 34Taxation and transfer pricing affect our operations and we could be subjected to additional taxes, duties, interest, and penalties in material amounts, which could harm our business

Risks Related to Owning Our Common Stock

  1. 35Our stock price is volatile and may fluctuate significantly
  2. 36Certain shareholders, directors, and officers own a significant amount of our stock, which could allow them to influence corporate transactions and other matters
  3. 37We have implemented anti-takeover provisions that may help discourage a change of control
  4. 38Our failure to comply with The Nasdaq Capital Market continued listing standards may adversely affect the price and liquidity of our shares of common stock as well as our ability to raise capital in the future
  5. 39We are not required to pay dividends, and our Board of Directors may decide not to declare dividends in the future
  6. 40The reduced disclosure requirements applicable to us as a "smaller reporting company" may make our common stock less attractive to investors

Other Mannatech 10-Ks

  • FY2025 10-K risk factors
    44 risks7 new3 dropped13 reworded

    Substantial doubt exists regarding the company's ability to continue as a going concern due to liquidity and operating results challenges. FDA import alerts on key products like Ambrotose Life and Ambrotose Complex create operational disruptions. International markets represent 79.3% of net sales, heightening foreign currency and regulatory exposures.

    Filed Apr 15, 2026

About this page

The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.